Skip to content

Treatment for Teachers With Vocal Fatigue

Cardiovascular Conditioning in the Treatment of Vocal Fatigue

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04486989
Enrollment
31
Registered
2020-07-27
Start date
2020-02-04
Completion date
2023-06-06
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment, Vocal Fatigue

Brief summary

Teachers are a population at high risk for voice disorders given their occupational demands. In a teaching career, a common debilitating symptom among all vocal symptoms experienced is - vocal fatigue, impacting teachers' occupational performance and increasing health care costs. It is therefore essential to identify potential treatment options to alleviate the symptom of vocal fatigue. The purpose of this study is to utilize a body-system level cardiovascular training protocol in comparison to traditional voice production training to alleviate the symptoms of vocal fatigue.

Interventions

BEHAVIORALCardiovascular Conditioning Protocol

Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.

OTHERVoice Production Exercises

Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.

Sponsors

East Tennessee State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Female teachers between the ages of 21-60 years Female instructors and college professors between the ages of 21-60 years * A score of ≥ 15 on factor 1 of the VFI (tiredness and avoidance of voice use) or a score of ≤ 5 on factor 3 of the VFI (improvement of symptoms or lack thereof with rest) * Sedentary- wherein participants will need to be completing mild intensity cardiovascular exercise less than 150 minutes in less than 5 days per week

Exclusion criteria

* Trained athletes * Trained singers * Smoking in the past 6months * Prior history of a vocal fold pathology and current vocal fold pathology

Design outcomes

Primary

MeasureTime frameDescription
Changes in Physiologic Cost of SpeakingAt baseline, at 4 weeks after treatmentPhysiologic Cost of Speaking is measured as the rate of oxygen consumption at steady state/ rate of speech (wpm) for each of the two reading tasks
Changes in Oxygen Uptake KineticsAt baseline, at 4 weeks after treatmentOxygen Uptake Kinetics is measured as the pattern of oxygen use during each of the two reading tasks
Changes in Post Task Physiological RecoveryAt baseline, at 4 weeks after treatmentPost Task Physiological Recovery is measured as the time, seconds, to reach baseline of oxygen consumption post task (within 0.2ml/kg/min) following each of the reading tasks
Changes in Excess Post Exercise Consumption (EPOC)At baseline, at 4 weeks after treatmentEPOC is measured as the magnitude of recovery oxygen consumption, ml/kg/min for each of the reading tasks
Changes in Ratings of Perceived Exertion (RPE)At baseline, at 4 weeks after treatmentBorg Scale of Ratings of Perceived Exertion (RPE)- measures the self-report of vocal effort for each of the reading tasks
Changes in Vocal Fatigue Index (VFI)At baseline, at 4 weeks after treatmentVocal Fatigue Index (VFI) is a retrospective scale that measures self-reported symptoms of vocal fatigue
Changes in Global Rating of Vocal Fatigue (VAS 100mm)At baseline, at 4 weeks after treatmentGlobal Rating of Vocal Fatigue (VAS 100mm) measures the ability to sustain voice with no fatigue at the end of a working day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026